GMED
Price
$57.80
Change
+$0.49 (+0.85%)
Updated
Jul 10 closing price
Capitalization
7.19B
20 days until earnings call
STE
Price
$230.72
Change
-$0.56 (-0.24%)
Updated
Jul 10 closing price
Capitalization
22.22B
31 days until earnings call
Interact to see
Advertisement

GMED vs STE

Header iconGMED vs STE Comparison
Open Charts GMED vs STEBanner chart's image
Globus Medical
Price$57.80
Change+$0.49 (+0.85%)
Volume$972.65K
Capitalization7.19B
STERIS
Price$230.72
Change-$0.56 (-0.24%)
Volume$530.75K
Capitalization22.22B
GMED vs STE Comparison Chart in %
Loading...
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GMED vs. STE commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMED is a StrongBuy and STE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (GMED: $57.80 vs. STE: $230.72)
Brand notoriety: GMED and STE are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GMED: 57% vs. STE: 85%
Market capitalization -- GMED: $7.19B vs. STE: $22.22B
GMED [@Medical Specialties] is valued at $7.19B. STE’s [@Medical Specialties] market capitalization is $22.22B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GMED’s FA Score shows that 0 FA rating(s) are green whileSTE’s FA Score has 1 green FA rating(s).

  • GMED’s FA Score: 0 green, 5 red.
  • STE’s FA Score: 1 green, 4 red.
According to our system of comparison, STE is a better buy in the long-term than GMED.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GMED’s TA Score shows that 3 TA indicator(s) are bullish while STE’s TA Score has 4 bullish TA indicator(s).

  • GMED’s TA Score: 3 bullish, 3 bearish.
  • STE’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both GMED and STE are a good buy in the short-term.

Price Growth

GMED (@Medical Specialties) experienced а -2.32% price change this week, while STE (@Medical Specialties) price change was -2.88% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.22%. For the same industry, the average monthly price growth was +1.80%, and the average quarterly price growth was +1.36%.

Reported Earning Dates

GMED is expected to report earnings on Nov 11, 2025.

STE is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Medical Specialties (+2.22% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STE($22.2B) has a higher market cap than GMED($7.19B). GMED has higher P/E ratio than STE: GMED (49.65) vs STE (38.85). STE YTD gains are higher at: 12.794 vs. GMED (-30.117). STE has higher annual earnings (EBITDA): 1.39B vs. GMED (347M). GMED has more cash in the bank: 518M vs. STE (196M). GMED has less debt than STE: GMED (520M) vs STE (3.51B). STE has higher revenues than GMED: STE (5.41B) vs GMED (1.57B).
GMEDSTEGMED / STE
Capitalization7.19B22.2B32%
EBITDA347M1.39B25%
Gain YTD-30.11712.794-235%
P/E Ratio49.6538.85128%
Revenue1.57B5.41B29%
Total Cash518M196M264%
Total Debt520M3.51B15%
FUNDAMENTALS RATINGS
GMED vs STE: Fundamental Ratings
GMED
STE
OUTLOOK RATING
1..100
1156
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
18
Undervalued
PROFIT vs RISK RATING
1..100
7843
SMR RATING
1..100
8470
PRICE GROWTH RATING
1..100
8555
P/E GROWTH RATING
1..100
9862
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

STE's Valuation (18) in the Medical Specialties industry is somewhat better than the same rating for GMED (80). This means that STE’s stock grew somewhat faster than GMED’s over the last 12 months.

STE's Profit vs Risk Rating (43) in the Medical Specialties industry is somewhat better than the same rating for GMED (78). This means that STE’s stock grew somewhat faster than GMED’s over the last 12 months.

STE's SMR Rating (70) in the Medical Specialties industry is in the same range as GMED (84). This means that STE’s stock grew similarly to GMED’s over the last 12 months.

STE's Price Growth Rating (55) in the Medical Specialties industry is in the same range as GMED (85). This means that STE’s stock grew similarly to GMED’s over the last 12 months.

STE's P/E Growth Rating (62) in the Medical Specialties industry is somewhat better than the same rating for GMED (98). This means that STE’s stock grew somewhat faster than GMED’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GMEDSTE
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
69%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
54%
Momentum
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
59%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
54%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
58%
Bearish Trend 1 day ago
50%
Advances
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 10 days ago
57%
Declines
ODDS (%)
Bearish Trend 4 days ago
57%
Bearish Trend 1 day ago
49%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
62%
Aroon
ODDS (%)
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
42%
View a ticker or compare two or three
Interact to see
Advertisement
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FDIS95.971.00
+1.05%
Fidelity MSCI Consumer Discret ETF
LSAT40.750.34
+0.83%
LeaderShares® AlphaFctr® Tctcl Fcsd ETF
DMAR39.710.04
+0.10%
FT Vest US Equity Deep Bffr ETF Mar
BBLB82.380.08
+0.10%
JPMorgan BetaBuilders U.S. TrsBd20+YrETF
NXTI30.96N/A
N/A
Simplify Next Intangible Core Index ETF